Vous êtes ici : Accueil > Projet MEDTECH4EUROPE

Europe | Nouvelles technologies | Santé ＆ sciences du vivant


MEDTECH4EUROPE

The MEDTECH project involves strengthening public policies (structural funding andregional policies) in favour of research, development and innovation facilities thatadvance medical technology. Eight European regions share good practices inelaborating future action plans for developing innovation ecosystems in the medicaltechnology sector.



Publié le 3 mai 2021

​


Optimizing the Impact of Public Policies in Favourof Research and Innovation Facilities in the Fieldof Medical Technologies

The MEDTECH project involves strengthening public policies (structural funding andregional policies) in favour of research, development and innovation facilities thatadvance medical technology. Eight European regions share good practices inelaborating future action plans for developing innovation ecosystems in the medicaltechnology sector.





 

Starting date : Jun. 2018 > Nov. 2022
 

Lifetime: 54 months


Program in support : Interreg Europe


 

Status project : in progress


CEA-Leti's contact :

Françoise Charbit


 

Project Coordinator: Auvergne-Rhône-Alpes Region (FR)

Partners:  

  • DE: Steinbeis-Europa-Zentrum der Steinbeis Innovation gGmbH
  • DK: The Capital Region of Denmark
  • FI: Helsinki-Uusimaa Regional Council
  • FR: Auvergne-Rhône-Alpes Region, CEA
  • HU: South Transdanubian Regional Innovation Agency Nonprofit Ltd
  • IT: Foundation Lombardy Cluster Technologies for Living Environment -TechForLife
  • NL: Province of Limburg
  • PL: Upper Silesian Agency for Entrepreneurship and development Ltd.(GAPR)


​Target market: n/a


​

Investment:  € 1.7 m.

EC Contribution: € 1.4 m.



Website


Stakes

  • CEA-Leti is expert partner in Europe’s Medtech4 consortium. Regional authorities or their legal representatives (clusters, development agencies) possess little internal expertise in medical technology innovation issues, future prospects for medical device markets and
    global trends in this sector. This project’s focus, specifically policy support to research, development and innovation facilities, is a key issue for CEA-Leti, which has built and
    commissioned two operating medtech research infrastructures, namely Clinatec and Nano-Bio in Grenoble, and has implemented technological research programmes in cooperation with the industry.

  • CEA-Leti provides methodological and technical assistance to the consortium based on its expertise in open innovation campuses, European medical device networks and cooperation with the medtech industry.

  • CEA-Leti is leading a number of project tasks:
    • Definition of common methodology to benchmark 8 regional policy instruments and their specific context (State of Play)
    • Benchmarking the 8 regions through Joint Cross Analysis
    • Advising the consortium throughout the project.

  • Expected outcomes for CEA-Leti:
    • Transfer of expertise in medical device innovation processes to European regions, in particular the Auvergne-Rhône-Alpes regional authority
    • Understanding existing and future issues in the use of European regional development funds and territorial cooperation as experienced by regional authorities
    • Planning future proposals for enhancing cooperation in a 4-part helical system (Research, Education, Industry, Public Authorities) in a European context
    • Preparing regional authorities for taking part in Public Private Partnerships as a leveraging effect among EU funds and in cooperation with the medical technology industry.


OBJECTIVES

  • Medtech4 Europe gathers eight European regions willing to cooperate in improving their public policies for research and innovation facilities advancing medical technology. Main output consists of eight local action plans based on exchange of experiences, benchmarking, interregional mapping and joint analysis, study visits and workshops. The main expected result is to improve the use of structural funds for strengthening RDI medical technology ecosystems and adapting business models of RDI facilities to the needs of companies and research and for developing interregional RDI projects.


IMPACT

  • Interregional cooperation and streamlined use of European regional development funds are growing trends seen in European public policies. The project will show how such cooperation has developed in a specific area:
    medical technology. Industry and innovation players such as research institutes will benefit from these new policies. Eight regions will invest in medical technology, each implementing its own action plan, and there will be improved networking among key regional medical technology hubs in Europe.